CPT1C and breast carcinoma: Additionally, in total breast cancer patients, the miR-200c-Low cohort exhibits a higher expression of CPT1C (Figure 6F), and a moderate negative correlation between the expression of CPT1C and miR-200c was also revealed by Spearman correlation analysis (R=0.18, P<0.0001; Figure 6G).